We show that transduction with the selected lead mLPA-specific TCR efficiently retargeted polyclonal T cells from a range of donors against CD1c-expressing acute leukemia cells in vitro, while sparing healthy CD1c-expressing circulating monocytes, Dendritic Cells (DC) and B cells. This evidence concerns the gene CD1C and acute leukemia.